Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Every year, America’s medical research pipeline produces new treatments, new technologies and new ways to improve patient care. Often, the real challenge is ensuring policy keeps pace with these ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

Innovations in early disease detection are poised to rapidly change health care. AI is already being integrated into the early cancer detection process - and early Alzheimer's tests may be reshaping ...

A Rice University laboratory has developed a continuously tunable method to find and quantify DNA and RNA biomarkers. Rice bioengineer David Zhang and his colleagues have developed a unique way to ...

Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid ...